NASDAQ:SEPN

Septerna (SEPN) Stock Price, News & Analysis

Septerna logo
$39.20 -0.25 (-0.63%)
Closing price 04:00 PM Eastern
Extended Trading
$39.16 -0.05 (-0.11%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Septerna Stock (NASDAQ:SEPN)

Advanced

Key Stats

Today's Range
$38.77
▼
$40.20
50-Day Range
$35.67
▼
$52.34
52-Week Range
$22.78
▼
$53.34
Volume
209,025 shs
Average Volume
419,224 shs
Market Capitalization
$1.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$56.78
Consensus Rating
Moderate Buy

Company Overview

Septerna is a clinical-stage biotechnology company developing medicines that target G protein-coupled receptors (GPCRs), a large family of proteins involved in many biological processes. The company is based in South San Francisco, California.

Its discovery platform is designed to identify drug candidates that act on GPCRs, including targets that have been difficult to address with conventional drug-development approaches. Septerna is advancing candidates for endocrine, metabolic and other disease areas, with an emphasis on small-molecule medicines.

Founded in 2021, Septerna has no marketed products; its work is focused on research and clinical development. The company has also pursued collaborations to apply its GPCR discovery capabilities to additional therapeutic programs.

AI Generated. May Contain Errors.

Septerna Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

SEPN MarketRank™: 
2.2579316028 of 5 stars

Septerna scored higher than 45% of companies evaluated by MarketBeat, and ranked 556th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Septerna has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 1 strong buy rating, 8 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Septerna has a consensus price target of $56.78, representing about 44.8% upside from its current price of $39.20.

  • Amount of Analyst Coverage

    Septerna has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Septerna's stock forecast and price target.
  • Earnings Growth

    Earnings for Septerna are expected to decrease in the coming year, from ($1.51) to ($2.19) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Septerna is -30.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Septerna is -30.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Septerna has a P/B Ratio of 4.36. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.62% of the float of Septerna has been sold short.
  • Short Interest Ratio / Days to Cover

    Septerna has a short interest ratio ("days to cover") of 11.95, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Septerna has recently decreased by 4.84%, indicating that investor sentiment is improving.
  • Dividend Yield

    Septerna does not currently pay a dividend.

  • Dividend Growth

    Septerna does not have a long track record of dividend growth.

  • News Sentiment

    Septerna has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Septerna this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Septerna insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,042,851.00 in company stock.

  • Percentage Held by Insiders

    5.80% of the stock of Septerna is held by insiders.

  • Percentage Held by Institutions

    Septerna has minimal institutional ownership at this time.

  • Read more about Septerna's insider trading history.
Receive SEPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Septerna and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SEPN Stock News Headlines

Septerna (NASDAQ:SEPN) CFO Sells $832,400.00 in Stock
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
Septerna (NASDAQ:SEPN) Director Sells $3,934,723.80 in Stock
See More Headlines

SEPN Stock Analysis - Frequently Asked Questions

Septerna's stock was trading at $27.88 at the start of the year. Since then, SEPN shares have increased by 40.6% and is now trading at $39.20.

Septerna, Inc. (NASDAQ:SEPN) announced its quarterly earnings results on Monday, November, 9th. The company reported ($0.57) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.42) by $0.16. The business earned $18.88 million during the quarter, compared to the consensus estimate of $20.78 million. Septerna had a negative net margin of 61.29% and a negative trailing twelve-month return on equity of 14.98%.

Septerna (SEPN) raised $256 million in an IPO on Friday, October 25th 2024. The company issued 16,000,000 shares at a price of $15.00-$17.00 per share.

Septerna's top institutional shareholders include RA Capital Management L.P. (11.57%), Samsara Biocapital LLC (6.45%), Goldman Sachs Group Inc. (6.35%) and State Street Corp (1.71%). Insiders that own company stock include Rock Ventures V LP Third, Elizabeth Bhatt, Daniel D Long, Alan Ezekowitz, Gil M Labrucherie and Samira Shaikhly.
View institutional ownership trends
.

Shares of SEPN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/09/2026
Today
11/19/2026
9th Annual Evercore ISI HealthCONx Conference
12/01/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:SEPN
Previous Symbol
NASDAQ:SEPN
CIK
1984086
Fax
N/A
Employees
130
Year Founded
2019

Price Target and Rating

High Price Target
$65.00
Low Price Target
$43.00
Potential Upside/Downside
+44.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$48.88 million
Net Margins
-61.29%
Pretax Margin
-55.11%
Return on Equity
-14.98%
Return on Assets
-10.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.84
Quick Ratio
4.84

Sales & Book Value

Annual Sales
$45.95 million
Price / Sales
40.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.00 per share
Price / Book
4.36

Miscellaneous

Outstanding Shares
47,550,000
Free Float
44,791,000
Market Cap
$1.86 billion
Optionable
Optionable
Beta
2.20

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:SEPN) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners